Robert E. Funck, Vice President, Controller at ABBOTT LABORATORIES (ABT), sold 4,542 shares at $38.97 ($180K) on 2014-03-03, disclosed to the SEC on 2014-03-04.
Scheduled sale ($180k) by Vice President, Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.79 | 3,129 | $125K | 69.3% |
| 2 | $38.97 | 700 | $27K | 15.2% |
| 3 | $38.97 | 713 | $28K | 15.5% |
| Total | $39.53 avg | 4,542 | $180K | 100% |
| Filing → |
| ABT | SELL | 2019-03-04 | $78K | — | Filing → |
| ABT | SELL | 2018-03-02 | $144K | — | Filing → |
| ABT | SELL | 2017-02-24 | $1.2M | — | Filing → |